NEW YORK, Dec. 9, 2013 /PRNewswire/ -- Bronstein,
Gewirtz & Grossman, LLC is investigating potential claims
against the Board of Directors of Given Imaging Ltd. ("Given
Imaging" or the "Company") (NasdaqGS:GIVN) related to the proposed
acquisition of the Company by Covidien PLC. The transaction is
valued at around $860 million or
$30 per share.
This investigation concerns whether the Board of Directors of
Given Imaging breached their fiduciary duties to stockholders by
failing to adequately shop the Company before agreeing to enter
into the proposed transaction, and whether the Company has
disclosed all material information to shareholders about the
transaction.
If you are aware of any facts relating to this investigation, or
purchased shares of Given Imaging, you can assist this
investigation by contacting either Peretz
Bronstein or his Investor Relations Coordinator Eitan Kimelman of Bronstein, Gewirtz &
Grossman, LLC at 212-697-6484 or via email info@bgandg.com. Those
who inquire by e-mail are encouraged to include their mailing
address and telephone number.
Bronstein, Gewirtz & Grossman, LLC is a corporate litigation
boutique. Our primary expertise is the aggressive pursuit of
litigation claims on behalf of our clients. In addition to
representing institutions and other investor plaintiffs in class
action security litigation, the firm's expertise includes general
corporate and commercial litigation, as well as securities
arbitration. Attorney advertising. Prior results do not
guarantee similar outcomes.
SOURCE Bronstein, Gewirtz & Grossman, LLC